$60.00
This product is strictly intended for use as a research chemical and is designated solely for in vitro testing and laboratory experimentation. All information provided on this website is for educational purposes only. Under no circumstances should this product be introduced into the human or animal body, as such actions are strictly prohibited by law. Handling of this product is restricted to licensed and qualified professionals. It is neither classified as a drug, food, nor cosmetic and must not be misbranded, misused, or misrepresented as such.
Tirzepatide is a synthetic compound derived from gastric inhibitory polypeptide (GIP), designed to mimic glucagon-like peptide-1 (GLP-1) activity as well. This dual functionality enables Tirzepatide to effectively lower blood glucose levels, enhance insulin sensitivity, and promote feelings of fullness. Originally developed for managing type 2 diabetes, research has also highlighted its potential to support cardiovascular health.
